Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (Q33499135)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group |
scientific article |
Statements
1 reference
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (English)
1 reference
Whitley RJ
1 reference
Cloud G
1 reference
Gruber W
1 reference
Storch GA
1 reference
Demmler GJ
1 reference
Jacobs RF
1 reference
Dankner W
1 reference
Spector SA
1 reference
Starr S
1 reference
Pass RF
1 reference
Stagno S
1 reference
Britt WJ
1 reference
Alford C Jr
1 reference
Soong S
1 reference
Zhou XJ
1 reference
Sherrill L
1 reference
FitzGerald JM
1 reference
Sommadossi JP
1 reference
1 reference